Home › Encyclopedia › FOXO4-DRI: Research Peptide Profile
Research / Unapproved

FOXO4-DRI: Research Peptide Profile

Drafted by an automated content engine from FDA, PubChem, ClinicalTrials.gov, NIH DSLD, and Open Beauty Facts data.

Molecular formulaC228H388N86O64
Molecular weight5358 g/mol
Registered trials0
PubChem CID167312269

Regulatory status

FOXO4-DRI is an unapproved research compound. It has no FDA-approved label, no approved brand name, and no established clinical indication.

What FOXO4-DRI is

FOXO4-DRI is a synthetic peptide built as a D-retro-inverso version of a sequence derived from the FOXO4 protein. This design uses D-amino acids arranged in reverse order, a strategy intended to resist normal enzymatic breakdown while preserving the shape of the original sequence. Chemically, it has the molecular formula C228H388N86O64 and a molecular weight of about 5,358 g/mol, cataloged under PubChem CID 167312269. No DailyMed label exists for this compound, and it carries no approved pharmacologic class or mechanism description in FDA labeling.

What the evidence shows

The dataset shows no registered clinical trials for FOXO4-DRI, and no individual trial records are available to describe. Any published work on this peptide falls outside FDA-regulated clinical development as reflected in this data.

FAQ

Is FOXO4-DRI FDA approved?
No. FOXO4-DRI has no FDA-approved label, no approved brand name, and no listed indication. It is classified here as an unapproved research compound.
What is FOXO4-DRI chemically?
It is a synthetic peptide with the molecular formula C228H388N86O64 and a molecular weight near 5,358 g/mol. It is built in a D-retro-inverso format, meaning it uses mirror-image amino acids assembled in reverse sequence order.
How many clinical trials have studied FOXO4-DRI?
The available registry data lists zero registered clinical trials for FOXO4-DRI. There are no phase or trial status details to report at this time.
Are there known side effects of FOXO4-DRI in humans?
No FDA adverse event report data is available for FOXO4-DRI in this dataset. Without human trial or label data, no side effect pattern can be summarized.
What does PubChem CID 167312269 refer to?
That identifier is the PubChem catalog number for FOXO4-DRI, used to reference its exact chemical structure. It links to the compound's molecular formula and structural data rather than any clinical information.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication. Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.

Sources: PubChem

Updated 2026-08-03